Results 101 to 110 of about 265 (112)

Zilebesiran - Eine 6-Monats-Spritze gegen Hypertonie

Österreichische Apothekerzeitung, 2023
openaire   +1 more source

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

JAMA - Journal of the American Medical Association
Frank Cole, Armida Balawon
exaly  

Biannual zilebesiran associated with substantial BP reductions 

Medicom Conference Report AHA 2023
openaire   +1 more source

Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension

JAMA - Journal of the American Medical Association
Manish Saxena, Steven Reynolds, Vincent Woo   +2 more
exaly  

KARDIA-2: Add-on zilebesiran effectively lowers blood pressure

Medicom Conference Report ACC 2024
openaire   +1 more source

Opening New Horizon of Novel Pharmacological “Zilebesiran” as siRNA-Based Therapeutics for Hypertension: A Systematic Review

Journal of Hypertension
G.W. Pradipta, A. R. Ismail, A. Maisyaroh, T. Koeshermanto, V. S. N. Widi, F. J. Umam, P.V. Mustafiza   +6 more
openaire   +1 more source

Zilebesiran in the Treatment of Hypertension: Molecular Insights, Clinical Trial Results, and Future Perspectives

Medical Science
Katarzyna Marcinkowska, Zofia Leżańska, Emil Pałyga, Joanna Sowińska, Mateusz Kwiatkowski, Karolina Siemińska, Natalia Paluszkiewicz, Sandra Bryg, Aleksandra Cieślak, Sara Demkow   +9 more
openaire   +1 more source

7-036 Bayesian meta-analysis of Zilebesiran's effect on 24-hour systolic blood pressure in hypertensive patients

Zahin Shahriar
exaly  

ZILEBESIRAN NO TRATAMENTO DA HIPERTENSÃO ARTERIAL: REVISÃO SISTEMÁTICA SOBRE EFICÁCIA E MECANISMO BASEADO EM INTERFERÊNCIA POR RNA

exaly  

Is zilebesiran a novel effective and uniquely administered agent for an expanding therapeutic armamentarium for blood pressure control?

AME Clinical Trials Review
openaire   +1 more source